| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |